Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options

Development of the Scalp Hair Assessment PRO™ measure for alopecia areata

(2020) K.W. Wyrwich et al.   BRITISH JOURNAL OF DERMATOLOGY

Cyclosporin for moderate to severe alopecia areata: a double-blind, randomized, placebo-controlled clinical trial of efficacy and safety

(2019) Vivien Wai Yun Lai et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Manuscript No 19-00107 Frontal Fibrosing Alopecia, Just Lichen Planopilaris?

(2019) Steven Kossard   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The Effect of Platelet Rich Plasma on Hair Re‐growth in Patients with Alopecia Areata Totalis: a Clinical Pilot Study

(2019) Faezeh Khademi et al.   Dermatologic Therapy

Method for describing patterns and distributions of alopecia areata which may be helpful for patient characterization and predicting prognosis

(2019) Hanil Lee et al.   JOURNAL OF DERMATOLOGY

Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation

(2019) Soheir Ghonemy et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

“The psychosocial burden of alopecia areata and androgenetica”: A Cross‐Sectional Multicenter Study among Dermatological Out‐Patients in 13 European Countries

(2019) Geraldine Titeca et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Increased Incidence of Thyroid Disease in Patients with Alopecia Areata: A Systematic Review and Meta-Analysis

(2019) Caihong Xin et al.   DERMATOLOGY

Alopecia totalis and universalis long‐term outcomes: a review

(2019) B. Burroway et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

An investigation of vitamin D status in alopecia areata

(2018) Venkata Krishna Vamsi Gade et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Nail changes in alopecia areata: an update and review

(2018) Khatiya Chelidze et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Trichoscopy of alopecia areata: An update

(2018) Anna Waśkiel et al.   JOURNAL OF DERMATOLOGY

Why Finding a Treatment for Alopecia Areata Is Important: A Multifaceted Perspective

(2018) Angela Renee Rodgers   JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS

Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta-analysis

(2018) S. Lee et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Development and pilot-testing of the Alopecia Areata Assessment Tool (ALTO)

(2018) David G. Li et al.   PLoS One

LOW DOSE DAILY ASPIRIN REDUCES TOPICAL MINOXIDIL EFFICACY IN ANDROGENETIC ALOPECIA PATIENTS

(2018) A. Goren et al.   Dermatologic Therapy

Serum level of IL-4 predicts response to topical immunotherapy with diphenylcyclopropenone in alopecia areata

(2018) Yugang Gong et al.   EXPERIMENTAL DERMATOLOGY

Platelet-Rich Plasma for Hair Loss

(2018) Karam W. Badran et al.   Facial Plastic Surgery Clinics of North America

A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata

(2018) Daniela Mikhaylov et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Improvement of alopecia areata with apremilast

(2018) Jorge Magdaleno-Tapial et al.   AUSTRALASIAN JOURNAL OF DERMATOLOGY

Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study

(2018) Nawaf Almutairi et al.   DERMATOLOGY

Next-generation dendritic cell-based vaccines for leukemia patients

(2017) Jean-Marc Hoffmann et al.   Immunotherapy

The Importance of Dendritic Cells in Maintaining Immune Tolerance

(2017) Cindy Audiger et al.   JOURNAL OF IMMUNOLOGY

Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata

(2017) Yong Hyun Jang et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients

(2017) Lucy Y. Liu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Tofacitinib for the treatment of alopecia areata and variants in adolescents

(2017) Brittany G. Craiglow et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis

(2017) Areej Adil et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Serum vitamin D level is related to disease severity in pediatric alopecia areata

(2017) Mehmet Unal et al.   Journal of Cosmetic Dermatology

Alopecia areata

(2017) C. Herbert Pratt et al.   Nature Reviews Disease Primers

Autologous Platelet-Rich Plasma for the Treatment of Pattern Hair Loss

(2016) Babu Singh et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies

(2016) Amos Gilhar et al.   AUTOIMMUNITY REVIEWS

Phototherapy for alopecia areata

(2016) Oliverio Welsh   CLINICS IN DERMATOLOGY

AIRE-mutations and autoimmune disease

(2016) Øyvind Bruserud et al.   CURRENT OPINION IN IMMUNOLOGY

Alopecia Areata Progression Index, a Scoring System for Evaluating Overall Hair Loss Activity in Alopecia Areata Patients with Pigmented Hair: A Development and Reliability Assessment

(2016) Yong Hyun Jang et al.   DERMATOLOGY

Biomarkers of alopecia areata disease activity and response to corticosteroid treatment

(2016) Judilyn Fuentes-Duculan et al.   EXPERIMENTAL DERMATOLOGY

A systematic review of pulse steroid therapy for alopecia areata

(2016) Rony Shreberk-Hassidim et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Alopecia Areata After Vaccination: Recurrence with Rechallenge

(2016) Chien-Ho Chu et al.   PEDIATRIC DERMATOLOGY

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis

(2016) Elisabetta Volpe et al.   Frontiers in Immunology

Evaluation of clinical significance of dermoscopy in alopecia areata

(2016) Chintaginjala Aruna et al.   INDIAN JOURNAL OF DERMATOLOGY

Central tolerance to self revealed by the autoimmune regulator

(2015) Alice Y. Chan et al.   Annals of the New York Academy of Sciences

The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention

(2015) John J. O'Shea et al.   Annual Review of Medicine

Effectiveness of 308-nm Excimer Laser Therapy in Treating Alopecia Areata, Determined by Examining the Treated Sides of Selected Alopecic Patches

(2015) Ji Won Byun et al.   DERMATOLOGY

Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing

(2015) Mayte Suárez-Fariñas et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo

(2015) Aviad Keren et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients

(2015) Katherine S. Chiang et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS

Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases

(2015) Daniella M. Schwartz et al.   Nature Reviews Rheumatology

The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial

(2015) Pietro Gentile et al.   Stem Cells Translational Medicine

Efficacy and safety of methotrexate in alopecia areata

(2014) Mariana Hammerschmidt et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events

(2014) David A. Geier et al.   CLINICAL RHEUMATOLOGY

Clinical utility and validity of minoxidil response testing in androgenetic alopecia

(2014) Andy Goren et al.   Dermatologic Therapy

Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis

(2014) Brittany G. Craiglow et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Plasmacytoid dendritic cells in alopecia areata: missing link?

(2014) J. Abou Rahal et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition

(2014) Luzhou Xing et al.   NATURE MEDICINE

New aspects of the treatment of alopecia areata

(2014) Ligia Brzezińska-Wcisło et al.   Postepy Dermatologii i Alergologii

Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment

(2013) B. Strober et al.   BRITISH JOURNAL OF DERMATOLOGY

A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis

(2013) W.C. Ports et al.   BRITISH JOURNAL OF DERMATOLOGY

Dendritic Cells: Cellular Mediators for Immunological Tolerance

(2013) Chun Yuen J. Chung et al.   Clinical & Developmental Immunology

Understanding Dendritic Cells and Their Role in Cutaneous Carcinoma and Cancer Immunotherapy

(2013) Valerie R. Yanofsky et al.   Clinical & Developmental Immunology

The effect of oral cyclosporine in the treatment of severe alopecia areata

(2013) Gürol Açıkgöz et al.   Cutaneous and Ocular Toxicology

Vitiligo and alopecia areata: apples and oranges?

(2013) John E. Harris   EXPERIMENTAL DERMATOLOGY

Human dendritic cell subsets

(2013) Matthew Collin et al.   IMMUNOLOGY

Peripheral Tissue Homing Receptors Enable T Cell Entry into Lymph Nodes and Affect the Anatomical Distribution of Memory Cells

(2013) C. C. Brinkman et al.   JOURNAL OF IMMUNOLOGY

Blocking Potassium Channels (Kv1.3): A New Treatment Option for Alopecia Areata?

(2013) Amos Gilhar et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Somatostatin Expression in Human Hair Follicles and Its Potential Role in Immune Privilege

(2013) Trisia Breitkopf et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Overview of Alopecia Areata

(2013) Maria K. Hordinsky   JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS

Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis

(2013) C. Mamolo et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year

(2012) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata - part II

(2012) Betina Werner et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study

(2012) K.A. Papp et al.   BRITISH JOURNAL OF DERMATOLOGY

Sudden whitening of the hair in an 82-year-old woman: the ‘overnight greying’ phenomenon

(2012) S. P. Tan et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic Cells

(2012) Muzlifah Haniffa et al.   IMMUNITY

CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase

(2012) Taisuke Ito et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Autoimmune Disease Induction in a Healthy Human Organ: A Humanized Mouse Model of Alopecia Areata

(2012) Amos Gilhar et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Tofacitinib (CP-690,550), a Janus Kinase Inhibitor for Dry Eye Disease

(2012) Shiao Hui (Melissa) Liew et al.   OPHTHALMOLOGY

Immune functions of the skin

(2011) Christine Bangert et al.   CLINICS IN DERMATOLOGY

Topical and intralesional therapies for alopecia areata

(2011) ABDULLAH ALKHALIFAH   Dermatologic Therapy

Alopecia areata: Clinical presentation, diagnosis, and unusual cases

(2011) ANDREAS M. FINNER   Dermatologic Therapy

Calcitonin gene-related peptide (CGRP) may award relative protection from interferon-γ-induced collapse of human hair follicle immune privilege

(2011) Michael Kinori et al.   EXPERIMENTAL DERMATOLOGY

Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?

(2011) Nathalie Cools et al.   Immunotherapy

Histologic features of alopecia areata other than peribulbar lymphocytic infiltrates

(2011) Steven J. Peckham et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Évaluation à long terme de l’efficacité du méthotrexate seul ou associé à de faibles doses de corticoïdes dans le traitement des pelades décalvantes totales

(2010) E. Chartaux et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Designing polymeric particles for antigen delivery

(2010) Stefaan De Koker et al.   CHEMICAL SOCIETY REVIEWS

Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin

(2010) Nikolaus Romani et al.   IMMUNOLOGICAL REVIEWS

Hair Follicles from Alopecia Areata Patients Exhibit Alterations in Immune Privilege-Associated Gene Expression in Advance of Hair Loss

(2010) Hoon Kang et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Collapse of Immune Privilege in Alopecia Areata: Coincidental or Substantial?

(2010) Amos Gilhar   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Genome-wide association study in alopecia areata implicates both innate and adaptive immunity

(2010) Lynn Petukhova et al.   NATURE

Stress and autoimmunity

(2009) Ljudmila Stojanovich   AUTOIMMUNITY REVIEWS

Dendritic cells: biology of the skin

(2009) Mascha J. Toebak et al.   CONTACT DERMATITIS

An uncontrolled, open label study of sulfasalazine in severe alopecia areata

(2009) Shahin Aghaei   Indian Journal of Dermatology Venereology & Leprology

Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history

(2008) P FITZGERALDBOCARSLY et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Treatment of persistent alopecia areata with sulfasalazine

(2008) Turaj Rashidi et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY